Search Results - VERWEEL, Gwenda

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Sustained Viral Suppression and Immune Recovery in HIV Type 1—Infected Children after 4 Years of Highly Active Antiretroviral Therapy

    Sustained Viral Suppression and Immune Recovery in HIV Type 1—Infected Children after 4 Years of Highly Active Antiretroviral Therapy by Fraaij, Pieter L. A., Verweel, Gwenda, van Rossum, Annemarie M. C., van Lochem, Ellen G., Schutten, Martin, Weemaes, Corry M. R., Hartwig, Nico G., Burger, David M., de Groot, Ronald

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Short- and Long-term Immunological and Virological Outcome in HIV-Infected Infants According to the Age at Antiretroviral Treatment Initiation

    Short- and Long-term Immunological and Virological Outcome in HIV-Infected Infants According to the Age at Antiretroviral Treatment Initiation by Goetghebuer, Tessa, Le Chenadec, Jerome, Haelterman, Edwige, Galli, Luisa, Dollfus, Catherine, Thorne, Claire, Judd, Ali, Keiser, Olivia, Ramos, Jose Tomas, Levy, Jack, Warszawski, Josiane

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Treatment With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children Is Associated With a Sustained Effect on Growth

    Treatment With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children Is Associated With a Sustained Effect on Growth by Verweel, Gwenda, van Rossum, Annemarie M. C, Hartwig, Nico G, Wolfs, Tom F. W, Scherpbier, Henriette J, de Groot, Ronald

    Published in Pediatrics (Evanston)
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Pharmacokinetics of a once-daily regimen of lopinavir/ritonavir in HIV-1-infected children

    Pharmacokinetics of a once-daily regimen of lopinavir/ritonavir in HIV-1-infected children by VAN DER LEE, Manon, VERWEEL, Gwenda, DE GROOT, Ronald, BURGER, David

    Published in Antiviral therapy
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and below

    Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and below by VERWEEL, Gwenda, BURGER, David M, SHEEHAN, Nancy L, BERGSHOEFF, Alina S, WARRIS, Adilia, VAN DER KNAAP, Linda C, DRIESSEN, Gertjan, DE GROOT, Ronald, HARTWIG, Nico G

    Published in Antiviral therapy
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Pharmacokinetics of lopinavir in HIV type-1-infected children taking the new tablet formulation once daily

    Pharmacokinetics of lopinavir in HIV type-1-infected children taking the new tablet formulation once daily by VAN DER FLIER, Michiel, VERWEEL, Gwenda, VAN DER KNAAP, Linda C, VAN JAARSVELD, Petronette, DRIESSEN, Gert-Jan, VAN DER LEE, Manon, HARTWIG, Nico G, BURGER, David M

    Published in Antiviral therapy
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected children

    Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected children by Bergshoeff, Alina S., Fraaij, Pieter L. A., Verweij, Corrien, van Rossum, Annemarie M. C., Verweel, Gwenda, Hartwig, Nico G., de Groot, Ronald, Burger, David M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Early vs deferred highly active antiretroviral therapy in HIV infected infants: a European Collaborative Cohort Study

    Early vs deferred highly active antiretroviral therapy in HIV infected infants: a European Collaborative Cohort Study by Goetghebuer, Tessa, Haelterman, Edwige, Le Chenadec, Jerome, Dollfus, Catherine, Gibb, Diana, Boyd, Katherine, Judd, Ali, Galli, Luisa, Gabiano, Clara, Ramos, Jose, Thorne, Claire, Marczynska, Magdalena, Keiser, Olivia, Ene, Luminita, Hainaut, Marc, Scherpbier, Henriette, Wintergerst, Uwe, Schmitz, Véronique, Verweel, Gwenda, Giaquinto, Carlo, Warszawski, Josiane, Levy, Jack

    Published in Retrovirology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth

    Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth by Verweel, Gwenda, van Rossum, Annemarie M.C, Hartwig, Nico G, Wolfs, Tom F.W, Scherpbier, Henriette J, de Groot, Ronald

    Published in Pediatrics (Evanston)
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: